Hypertension 2019 Scientific Sessions
New Orleans Marriott | New Orleans, Louisiana
Sponsored by: Council on Hypertension
Council on Kidney in Cardiovascular Disease

All abstract submissions are now closed for 2019.
See details on Submission Categories, Rules and Guidelines
New for 2019
- Photos from Hypertension 2019 Scientific Sessions (opens in new window)
- Slides: AHA Research: Grant Funding and Other Opportunities (PDF)
- Hypertension 2019 Abstracts published in Hypertension
- Online Program Planner (opens in new window)
- Hypertension 2019 Final Program (PDF)
- Program agendas and details on Programming Page
Why You Should Attend #Hypertension19
Considered one of the most important medical meetings on this subject in the world, the conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions led by leading authorities. With experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity, and genetics, attendees will have the opportunity to connect with cross-disciplinary researchers from around the world.
This meeting also includes several interactive sessions specifically designed to benefit trainees and early career investigators, including a trainee poster session to highlight innovative research and how-to sessions that provide in-depth information about a range of topics related to the study of hypertension as well as The Clinical Practice Clinical Science Track focuses on applying clinical science to the clinician’s practice and the Primary Care Track is a "Meeting within a Meeting" dedicated to practical advice for the Primary Care Provider (PCP) interested in clinical hypertension.
2019 Key Dates
Date | Event |
---|---|
Feb. 13, 2019 | Abstract & Awards Submission Open |
April 17, 2019 | Registration opens |
May 13, 2019 | NEW DATE Abstracts close at 5:00 p.m. CDT |
May 15, 2019 | Late-Breaking Abstracts Submitter Open |
June 4, 2019 | Late-Breaking Abstracts Submission Deadline |
July 9, 2019 | Early Bird Registration Deadline |
July 10, 2019 | Advance Registration Begins |
July 30, 2019 | Advance Registration Deadline |
July 31, 2019 | Standard Registration begins |
Sept. 5-8, 2019 | Hypertension Scientific Sessions |
Accreditation
In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Heart Association designates this live activity for a maximum of 26.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 26.00 hours of Category I credit for completing this program.
AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
**AMA Credit must be claimed within 6 months of attendance. Credit will no longer be available to claim after March 8, 2020.
ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 26.00 contact hours.
**ANCC Credit must be claimed within 6 months of attendance. CME/CE will no longer be available to claim after March 8, 2020.
Disclosure Policy
All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.
Additional Resources
RESOURCES FOR PRESENTERS
Hypertension 2019 Submission Categories (PDF)Hypertension 2019 Submission Rules and Guidelines (PDF)
Hypertension 2019 Sample Disclosure Slide (PDF)
Hypertension 2019 AV Guidelines for Oral Abstracts, Invited Speakers and Moderators (PDF)
Hypertension 2019 Poster Presentation Guidelines (PDF)
Join or renew your AHA/ASA Professional Membership today to save on registration for all AHA Scientific Sessions.
JOIN NOW
E-mail: scientificconferences@heart.org
Phone: (888) 242-2453 or (214) 570-5935
Exhibit Information and Application
Julie Davis| (214) 706-1943